MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs) have had a profound impact on the treatment of many tumors; however, their effectiveness against triple-negative breast cancers (TNBCs) has been limited. One factor limiting responsiveness of TNBCs to ICIs is a lack of functional tumor-infiltrating lym...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Immunother Cancer
Päätekijät: Yamashita, Nami, Long, Mark, Fushimi, Atsushi, Yamamoto, Masaaki, Hata, Tsuyoshi, Hagiwara, Masayuki, Bhattacharya, Atrayee, Hu, Qiang, Wong, Kwok-Kin, Liu, Song, Kufe, Donald
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2021
Aiheet:
Clinical/Translational Cancer Immunotherapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839859/
https://ncbi.nlm.nih.gov/pubmed/33495298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002115
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia